
Our commitment to maintaining high-quality standards makes us a trusted partner. We adhere to GLP principles to ensure your preclinical drug development is backed by reliable and reproducible results.
KCI Biotech boasts a team of over 200 professionals with extensive backgrounds in preclinical research. Their expertise strengthens our capability to deliver precise and effective solutions tailored to your project requirements.
We understand the diverse needs of our clients, which is why we offer flexible minimum order quantities. This flexibility ensures that you can engage our services without unnecessary commitments.
Our one-stop preclinical CRO services cover all aspects of drug development. From pharmacology studies to toxicology and pathology, we provide a holistic approach to meet your research needs effectively.





Comprehensive preclinical drug development and service platform
Building A2, No, 8 Yanghua road, Suzhou industrial Park, Suzhou.P.R, china